+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sterile Injectable Drugs Market by Type, Drug Class, Administration Route, Dosage Form, Therapeutic Application, Distribution Channel - Global Forecast to 2030- Product Image
Sterile Injectable Drugs Market by Type, Drug Class, Administration Route, Dosage Form, Therapeutic Application, Distribution Channel - Global Forecast to 2030- Product Image
Sale

Sterile Injectable Drugs Market by Type, Drug Class, Administration Route, Dosage Form, Therapeutic Application, Distribution Channel - Global Forecast to 2030

  • PDF Icon

    Report

  • 183 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6012135
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The sterile injectable drugs market is rapidly evolving, driven by innovation in biotechnologies, higher regulatory demands, and the global push for safe, efficient therapies. Senior decision-makers need concise, actionable insights to navigate this complex landscape and capture growth opportunities in the sterile injectables space.

Market Snapshot: Sterile Injectable Drugs Market

From 2024 to 2025, the sterile injectable drugs market is positioned for notable expansion, progressing from USD 550.55 billion to USD 592.97 billion, with strong momentum projected through 2030 at a CAGR of 7.64% and an estimated USD 856.50 billion valuation. This growth reflects increasing global reliance on advanced biologics, expanding chronic disease management, and rapid innovation in delivery formats and manufacturing technology.

Scope & Segmentation

  • Type: Large Molecule, Small Molecule
  • Drug Class: Blood Factors, Chemotherapy Agents, Cytokines, Immunoglobulin, Insulin, Monoclonal Antibody, Peptide Antibiotics, Peptide Hormones, Small Molecule Antibiotics, Vaccines
  • Administration Route: Intradermal, Intramuscular, Intravenous, Subcutaneous
  • Dosage Form: Multi-Dose, Single Dose (including Ampoules, Pre-filled Syringes)
  • Therapeutic Application: Cardiology (Congestive Heart Failure, Hypertension, Myocardial Infarction), Hormonal Disorders (Adrenal Disorders, Thyroid Disorders), Infectious Diseases (Bacterial, Fungal, Viral Infections), Metabolic Disorders (Diabetes, Obesity), Neurological Disorders (Multiple Sclerosis, Parkinson's Disease), Oncology (Breast, Colorectal, Lung Cancer)
  • Distribution Channel: E-commerce, Hospital Pharmacy, Retail Pharmacy
  • Geographical Coverage: Americas (key states and countries), Europe, Middle East & Africa (wide range of nations), Asia-Pacific (including China, India, Japan, Australia, South Korea, and more)
  • Key Company Profiles: Adare Pharma Solutions, Aenova Group, Almac Group, Avara Pharmaceutical Services, Baxter International, Boehringer Ingelheim, Catalent, CordenPharma, Eli Lilly, Evonik Industries, Roche, Famar Group, Fresenius Kabi, Grifols, Hikma, Jubilant Pharmova, Nexus Pharmaceuticals, Patheon (Thermo Fisher Scientific), Pfizer, Recipharm, Serum Institute of India, Siegfried Holding AG
  • Technological Focus: Continuous manufacturing, real-time process analytics, cleanroom innovation, single-use systems, serialization, and traceability solutions

Sterile Injectable Drugs Market: Key Takeaways for Decision-Makers

  • Biologic and antibody-based injectables are increasingly prioritized, especially for targeted therapies and complex disease management, shifting portfolio strategies among leading pharmaceutical players.
  • Adoption of continuous and single-use manufacturing platforms is enabling greater agility and efficiency for both large firms and contract manufacturing organizations, supporting more responsive supply chains.
  • Quality control is being transformed by advanced analytics and artificial intelligence, enabling earlier detection and prevention of manufacturing deviations and improving regulatory compliance.
  • Global demand for convenient, patient-centric formats—such as pre-filled syringes and autoinjectors—is rising, particularly in home-care settings and for chronic disease therapies.
  • Regulatory scrutiny is intensifying, requiring robust process validation, contamination control, and traceability from all stakeholders to ensure high product and patient safety standards.
  • Emerging digital supply chain and serialization technologies are now essential for product security and for addressing transparency requirements across key markets.

Tariff Impact: Navigating U.S. Policy Shifts

2025 saw new U.S. tariffs on certain pharmaceutical imports, increasing supply chain and cost pressures within the sterile injectable segment. Many manufacturers have responded by restructuring supplier networks, exploring nearshoring options, and reinvesting in localized production capacity. These moves are fostering expedited regulatory engagement and the pursuit of harmonized approval pathways to maintain market access and mitigate disruptions.

Methodology & Data Sources

This analysis draws on primary interviews with industry executives, process engineers, and regulatory experts, along with case studies of major fill-finish facilities. Supporting sources include regulatory filings, peer-reviewed publications, company whitepapers, and expert panels. The research integrates value chain mapping, risk assessments, and scenario analyses to test conclusions and ensure data robustness.

Why This Report Matters to Senior Leaders

  • Enables strategic investment decisions with precise segmentation, technology, and regional opportunity mapping.
  • Clarifies shifting regulatory, manufacturing, and trade landscapes so leaders can proactively adapt and safeguard competitive advantage.
  • Provides actionable insight into patient-centered delivery innovations and evolving supply chain practices essential for future-proofing portfolios.

Conclusion

As sterile injectable drugs become more central to healthcare delivery, industry leaders require nuanced, data-driven guidance. This report provides senior decision-makers the analytical depth and foresight needed to chart a sustainable path in a dynamic global market.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Sterile Injectable Drugs Market, by Type
8.1. Introduction
8.2. Large Molecule
8.3. Small Molecule
9. Sterile Injectable Drugs Market, by Drug Class
9.1. Introduction
9.2. Blood Factors
9.3. Chemotherapy Agents
9.4. Cytokines
9.5. Immunoglobulin
9.6. Insulin
9.7. Monoclonal Antibody
9.8. Peptide Antibiotics
9.9. Peptide Hormones
9.10. Small Molecule Antibiotics
9.11. Vaccines
10. Sterile Injectable Drugs Market, by Administration Route
10.1. Introduction
10.2. Intradermal
10.3. Intramuscular
10.4. Intravenous
10.5. Subcutaneous
11. Sterile Injectable Drugs Market, by Dosage Form
11.1. Introduction
11.2. Multi-Dose
11.3. Single Dose
11.3.1. Ampoules
11.3.2. Pre-filled Syringes
12. Sterile Injectable Drugs Market, by Therapeutic Application
12.1. Introduction
12.2. Cardiology
12.2.1. Congestive Heart Failure
12.2.2. Hypertension
12.2.3. Myocardial Infarction
12.3. Hormonal Disorders
12.3.1. Adrenal Disorders
12.3.2. Thyroid Disorders
12.4. Infectious Diseases
12.4.1. Bacterial Infections
12.4.2. Fungal Infections
12.4.3. Viral Infections
12.5. Metabolic Disorders
12.5.1. Diabetes
12.5.2. Obesity
12.6. Neurological Disorders
12.6.1. Multiple Sclerosis
12.6.2. Parkinson's Disease
12.7. Oncology
12.7.1. Breast Cancer
12.7.2. Colorectal Cancer
12.7.3. Lung Cancer
13. Sterile Injectable Drugs Market, by Distribution Channel
13.1. Introduction
13.2. E-commerce
13.3. Hospital Pharmacy
13.4. Retail Pharmacy
14. Americas Sterile Injectable Drugs Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Sterile Injectable Drugs Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Sterile Injectable Drugs Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Adare Pharma Solutions
17.3.2. Aenova Group
17.3.3. Almac Group
17.3.4. Avara Pharmaceutical Services, Inc.
17.3.5. Baxter International Inc.
17.3.6. Boehringer Ingelheim International GmbH
17.3.7. Catalent, Inc.
17.3.8. CordenPharma
17.3.9. Eli Lilly and Company
17.3.10. Evonik Industries AG
17.3.11. F. Hoffmann-La Roche Ltd
17.3.12. Famar Group
17.3.13. Fresenius Kabi AG
17.3.14. Grifols S.A.
17.3.15. Hikma Pharmaceuticals PLC
17.3.16. Jubilant Pharmova Limited
17.3.17. Nexus Pharmaceuticals, Inc.
17.3.18. Patheon by hermo Fisher Scientific Inc.
17.3.19. Pfizer Inc.
17.3.20. Recipharm AB
17.3.21. Serum Institute of India Pvt. Ltd.
17.3.22. Siegfried Holding AG
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. STERILE INJECTABLE DRUGS MARKET MULTI-CURRENCY
FIGURE 2. STERILE INJECTABLE DRUGS MARKET MULTI-LANGUAGE
FIGURE 3. STERILE INJECTABLE DRUGS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL STERILE INJECTABLE DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL STERILE INJECTABLE DRUGS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL STERILE INJECTABLE DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL STERILE INJECTABLE DRUGS MARKET SIZE, BY TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL STERILE INJECTABLE DRUGS MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL STERILE INJECTABLE DRUGS MARKET SIZE, BY DRUG CLASS, 2024 VS 2030 (%)
FIGURE 10. GLOBAL STERILE INJECTABLE DRUGS MARKET SIZE, BY DRUG CLASS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL STERILE INJECTABLE DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL STERILE INJECTABLE DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL STERILE INJECTABLE DRUGS MARKET SIZE, BY DOSAGE FORM, 2024 VS 2030 (%)
FIGURE 14. GLOBAL STERILE INJECTABLE DRUGS MARKET SIZE, BY DOSAGE FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL STERILE INJECTABLE DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024 VS 2030 (%)
FIGURE 16. GLOBAL STERILE INJECTABLE DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL STERILE INJECTABLE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 18. GLOBAL STERILE INJECTABLE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS STERILE INJECTABLE DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS STERILE INJECTABLE DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES STERILE INJECTABLE DRUGS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES STERILE INJECTABLE DRUGS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA STERILE INJECTABLE DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA STERILE INJECTABLE DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC STERILE INJECTABLE DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC STERILE INJECTABLE DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. STERILE INJECTABLE DRUGS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. STERILE INJECTABLE DRUGS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. STERILE INJECTABLE DRUGS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL STERILE INJECTABLE DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL STERILE INJECTABLE DRUGS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL STERILE INJECTABLE DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL STERILE INJECTABLE DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL STERILE INJECTABLE DRUGS MARKET SIZE, BY LARGE MOLECULE, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL STERILE INJECTABLE DRUGS MARKET SIZE, BY SMALL MOLECULE, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL STERILE INJECTABLE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL STERILE INJECTABLE DRUGS MARKET SIZE, BY BLOOD FACTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL STERILE INJECTABLE DRUGS MARKET SIZE, BY CHEMOTHERAPY AGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL STERILE INJECTABLE DRUGS MARKET SIZE, BY CYTOKINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL STERILE INJECTABLE DRUGS MARKET SIZE, BY IMMUNOGLOBULIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL STERILE INJECTABLE DRUGS MARKET SIZE, BY INSULIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL STERILE INJECTABLE DRUGS MARKET SIZE, BY MONOCLONAL ANTIBODY, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL STERILE INJECTABLE DRUGS MARKET SIZE, BY PEPTIDE ANTIBIOTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL STERILE INJECTABLE DRUGS MARKET SIZE, BY PEPTIDE HORMONES, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL STERILE INJECTABLE DRUGS MARKET SIZE, BY SMALL MOLECULE ANTIBIOTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL STERILE INJECTABLE DRUGS MARKET SIZE, BY VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL STERILE INJECTABLE DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL STERILE INJECTABLE DRUGS MARKET SIZE, BY INTRADERMAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL STERILE INJECTABLE DRUGS MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL STERILE INJECTABLE DRUGS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL STERILE INJECTABLE DRUGS MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL STERILE INJECTABLE DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL STERILE INJECTABLE DRUGS MARKET SIZE, BY MULTI-DOSE, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL STERILE INJECTABLE DRUGS MARKET SIZE, BY SINGLE DOSE, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL STERILE INJECTABLE DRUGS MARKET SIZE, BY AMPOULES, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL STERILE INJECTABLE DRUGS MARKET SIZE, BY PRE-FILLED SYRINGES, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL STERILE INJECTABLE DRUGS MARKET SIZE, BY SINGLE DOSE, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL STERILE INJECTABLE DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL STERILE INJECTABLE DRUGS MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL STERILE INJECTABLE DRUGS MARKET SIZE, BY CONGESTIVE HEART FAILURE, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL STERILE INJECTABLE DRUGS MARKET SIZE, BY HYPERTENSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL STERILE INJECTABLE DRUGS MARKET SIZE, BY MYOCARDIAL INFARCTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL STERILE INJECTABLE DRUGS MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL STERILE INJECTABLE DRUGS MARKET SIZE, BY HORMONAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL STERILE INJECTABLE DRUGS MARKET SIZE, BY ADRENAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL STERILE INJECTABLE DRUGS MARKET SIZE, BY THYROID DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL STERILE INJECTABLE DRUGS MARKET SIZE, BY HORMONAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL STERILE INJECTABLE DRUGS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL STERILE INJECTABLE DRUGS MARKET SIZE, BY BACTERIAL INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL STERILE INJECTABLE DRUGS MARKET SIZE, BY FUNGAL INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL STERILE INJECTABLE DRUGS MARKET SIZE, BY VIRAL INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL STERILE INJECTABLE DRUGS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL STERILE INJECTABLE DRUGS MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL STERILE INJECTABLE DRUGS MARKET SIZE, BY DIABETES, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL STERILE INJECTABLE DRUGS MARKET SIZE, BY OBESITY, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL STERILE INJECTABLE DRUGS MARKET SIZE, BY METABOLIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL STERILE INJECTABLE DRUGS MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL STERILE INJECTABLE DRUGS MARKET SIZE, BY MULTIPLE SCLEROSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL STERILE INJECTABLE DRUGS MARKET SIZE, BY PARKINSON'S DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL STERILE INJECTABLE DRUGS MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL STERILE INJECTABLE DRUGS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL STERILE INJECTABLE DRUGS MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL STERILE INJECTABLE DRUGS MARKET SIZE, BY COLORECTAL CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL STERILE INJECTABLE DRUGS MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL STERILE INJECTABLE DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL STERILE INJECTABLE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL STERILE INJECTABLE DRUGS MARKET SIZE, BY E-COMMERCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL STERILE INJECTABLE DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL STERILE INJECTABLE DRUGS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS STERILE INJECTABLE DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS STERILE INJECTABLE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS STERILE INJECTABLE DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS STERILE INJECTABLE DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 67. AMERICAS STERILE INJECTABLE DRUGS MARKET SIZE, BY SINGLE DOSE, 2018-2030 (USD MILLION)
TABLE 68. AMERICAS STERILE INJECTABLE DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 69. AMERICAS STERILE INJECTABLE DRUGS MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
TABLE 70. AMERICAS STERILE INJECTABLE DRUGS MARKET SIZE, BY HORMONAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 71. AMERICAS STERILE INJECTABLE DRUGS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 72. AMERICAS STERILE INJECTABLE DRUGS MARKET SIZE, BY METABOLIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 73. AMERICAS STERILE INJECTABLE DRUGS MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 74. AMERICAS STERILE INJECTABLE DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 75. AMERICAS STERILE INJECTABLE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 76. AMERICAS STERILE INJECTABLE DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 77. UNITED STATES STERILE INJECTABLE DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 78. UNITED STATES STERILE INJECTABLE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 79. UNITED STATES STERILE INJECTABLE DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 80. UNITED STATES STERILE INJECTABLE DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 81. UNITED STATES STERILE INJECTABLE DRUGS MARKET SIZE, BY SINGLE DOSE, 2018-2030 (USD MILLION)
TABLE 82. UNITED STATES STERILE INJECTABLE DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 83. UNITED STATES STERILE INJECTABLE DRUGS MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
TABLE 84. UNITED STATES STERILE INJECTABLE DRUGS MARKET SIZE, BY HORMONAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 85. UNITED STATES STERILE INJECTABLE DRUGS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 86. UNITED STATES STERILE INJECTABLE DRUGS MARKET SIZE, BY METABOLIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 87. UNITED STATES STERILE INJECTABLE DRUGS MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 88. UNITED STATES STERILE INJECTABLE DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 89. UNITED STATES STERILE INJECTABLE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 90. UNITED STATES STERILE INJECTABLE DRUGS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 91. CANADA STERILE INJECTABLE DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 92. CANADA STERILE INJECTABLE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 93. CANADA STERILE INJECTABLE DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 94. CANADA STERILE INJECTABLE DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 95. CANADA STERILE INJECTABLE DRUGS MARKET SIZE, BY SINGLE DOSE, 2018-2030 (USD MILLION)
TABLE 96. CANADA STERILE INJECTABLE DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 97. CANADA STERILE INJECTABLE DRUGS MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
TABLE 98. CANADA STERILE INJECTABLE DRUGS MARKET SIZE, BY HORMONAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 99. CANADA STERILE INJECTABLE DRUGS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 100. CANADA STERILE INJECTABLE DRUGS MARKET SIZE, BY METABOLIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 101. CANADA STERILE INJECTABLE DRUGS MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 102. CANADA STERILE INJECTABLE DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 103. CANADA STERILE INJECTABLE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 104. MEXICO STERILE INJECTABLE DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 105. MEXICO STERILE INJECTABLE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 106. MEXICO STERILE INJECTABLE DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 107. MEXICO STERILE INJECTABLE DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 108. MEXICO STERILE INJECTABLE DRUGS MARKET SIZE, BY SINGLE DOSE, 2018-2030 (USD MILLION)
TABLE 109. MEXICO STERILE INJECTABLE DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 110. MEXICO STERILE INJECTABLE DRUGS MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
TABLE 111. MEXICO STERILE INJECTABLE DRUGS MARKET SIZE, BY HORMONAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 112. MEXICO STERILE INJECTABLE DRUGS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 113. MEXICO STERILE INJECTABLE DRUGS MARKET SIZE, BY METABOLIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 114. MEXICO STERILE INJECTABLE DRUGS MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 115. MEXICO STERILE INJECTABLE DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 116. MEXICO STERILE INJECTABLE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 117. BRAZIL STERILE INJECTABLE DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 118. BRAZIL STERILE INJECTABLE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 119. BRAZIL STERILE INJECTABLE DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 120. BRAZIL STERILE INJECTABLE DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 121. BRAZIL STERILE INJECTABLE DRUGS MARKET SIZE, BY SINGLE DOSE, 2018-2030 (USD MILLION)
TABLE 122. BRAZIL STERILE INJECTABLE DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 123. BRAZIL STERILE INJECTABLE DRUGS MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
TABLE 124. BRAZIL STERILE INJECTABLE DRUGS MARKET SIZE, BY HORMONAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 125. BRAZIL STERILE INJECTABLE DRUGS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 126. BRAZIL STERILE INJECTABLE DRUGS MARKET SIZE, BY METABOLIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 127. BRAZIL STERILE INJECTABLE DRUGS MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 128. BRAZIL STERILE INJECTABLE DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 129. BRAZIL STERILE INJECTABLE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 130. ARGENTINA STERILE INJECTABLE DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 131. ARGENTINA STERILE INJECTABLE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 132. ARGENTINA STERILE INJECTABLE DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 133. ARGENTINA STERILE INJECTABLE DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 134. ARGENTINA STERILE INJECTABLE DRUGS MARKET SIZE, BY SINGLE DOSE, 2018-2030 (USD MILLION)
TABLE 135. ARGENTINA STERILE INJECTABLE DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 136. ARGENTINA STERILE INJECTABLE DRUGS MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
TABLE 137. ARGENTINA STERILE INJECTABLE DRUGS MARKET SIZE, BY HORMONAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 138. ARGENTINA STERILE INJECTABLE DRUGS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 139. ARGENTINA STERILE INJECTABLE DRUGS MARKET SIZE, BY METABOLIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 140. ARGENTINA STERILE INJECTABLE DRUGS MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 141. ARGENTINA STERILE INJECTABLE DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 142. ARGENTINA STERILE INJECTABLE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 143. EUROPE, MIDDLE EAST & AFRICA STERILE INJECTABLE DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 144. EUROPE, MIDDLE EAST & AFRICA STERILE INJECTABLE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA STERILE INJECTABLE DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA STERILE INJECTABLE DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA STERILE INJECTABLE DRUGS MARKET SIZE, BY SINGLE DOSE, 2018-2030 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA STERILE INJECTABLE DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA STERILE INJECTABLE DRUGS MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA STERILE INJECTABLE DRUGS MARKET SIZE, BY HORMONAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA STERILE INJECTABLE DRUGS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA STERILE INJECTABLE DRUGS MARKET SIZE, BY METABOLIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA STERILE INJECTABLE DRUGS MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA STERILE INJECTABLE DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA STERILE INJECTABLE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA STERILE INJECTABLE DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 157. UNITED KINGDOM STERILE INJECTABLE DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 158. UNITED KINGDOM STERILE INJECTABLE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 159. UNITED KINGDOM STERILE INJECTABLE DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 160. UNITED KINGDOM STERILE INJECTABLE DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 161. UNITED KINGDOM STERILE INJECTABLE DRUGS MARKET SIZE, BY SINGLE DOSE, 2018-2030 (USD MILLION)
TABLE 162. UNITED KINGDOM STERILE INJECTABLE DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 163. UNITED KINGDOM STERILE INJECTABLE DRUGS MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
TABLE 164. UNITED KINGDOM STERILE INJECTABLE DRUGS MARKET SIZE, BY HORMONAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 165. UNITED KINGDOM STERILE INJECTABLE DRUGS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 166. UNITED KINGDOM STERILE INJECTABLE DRUGS MARKET SIZE, BY METABOLIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 167. UNITED KINGDOM STERILE INJECTABLE DRUGS MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 168. UNITED KINGDOM STERILE INJECTABLE DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 169. UNITED KINGDOM STERILE INJECTABLE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 170. GERMANY STERILE INJECTABLE DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 171. GERMANY STERILE INJECTABLE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 172. GERMANY STERILE INJECTABLE DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 173. GERMANY STERILE INJECTABLE DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 174. GERMANY STERILE INJECTABLE DRUGS MARKET SIZE, BY SINGLE DOSE, 2018-2030 (USD MILLION)
TABLE 175. GERMANY STERILE INJECTABLE DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 176. GERMANY STERILE INJECTABLE DRUGS MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
TABLE 177. GERMANY STERILE INJECTABLE DRUGS MARKET SIZE, BY HORMONAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 178. GERMANY STERILE INJECTABLE DRUGS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 179. GERMANY STERILE INJECTABLE DRUGS MARKET SIZE, BY METABOLIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 180. GERMANY STERILE INJECTABLE DRUGS MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 181. GERMANY STERILE INJECTABLE DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 182. GERMANY STERILE INJECTABLE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 183. FRANCE STERILE INJECTABLE DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 184. FRANCE STERILE INJECTABLE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 185. FRANCE STERILE INJECTABLE DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 186. FRANCE STERILE INJECTABLE DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 187. FRANCE STERILE INJECTABLE DRUGS MARKET SIZE, BY SINGLE DOSE, 2018-2030 (USD MILLION)
TABLE 188. FRANCE STERILE INJECTABLE DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 189. FRANCE STERILE INJECTABLE DRUGS MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
TABLE 190. FRANCE STERILE INJECTABLE DRUGS MARKET SIZE, BY HORMONAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 191. FRANCE STERILE INJECTABLE DRUGS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 192. FRANCE STERILE INJECTABLE DRUGS MARKET SIZE, BY METABOLIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 193. FRANCE STERILE INJECTABLE DRUGS MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 194. FRANCE STERILE INJECTABLE DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 195. FRANCE STERILE INJECTABLE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 196. RUSSIA STERILE INJECTABLE DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 197. RUSSIA STERILE INJECTABLE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 198. RUSSIA STERILE INJECTABLE DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 199. RUSSIA STERILE INJECTABLE DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 200. RUSSIA STERILE INJECTABLE DRUGS MARKET SIZE, BY SINGLE DOSE, 2018-2030 (USD MILLION)
TABLE 201. RUSSIA STERILE INJECTABLE DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 202. RUSSIA STERILE INJECTABLE DRUGS MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
TABLE 203. RUSSIA STERILE INJECTABLE DRUGS MARKET SIZE, BY HORMONAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 204. RUSSIA STERILE INJECTABLE DRUGS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 205. RUSSIA STERILE INJECTABLE DRUGS MARKET SIZE, BY METABOLIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 206. RUSSIA STERILE INJECTABLE DRUGS MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 207. RUSSIA STERILE INJECTABLE DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 208. RUSSIA STERILE INJECTABLE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 209. ITALY STERILE INJECTABLE DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 210. ITALY STERILE INJECTABLE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 211. ITALY STERILE INJECTABLE DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 212. ITALY STERILE INJECTABLE DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 213. ITALY STERILE INJECTABLE DRUGS MARKET SIZE, BY SINGLE DOSE, 2018-2030 (USD MILLION)
TABLE 214. ITALY STERILE INJECTABLE DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 215. ITALY STERILE INJECTABLE DRUGS MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
TABLE 216. ITALY STERILE INJECTABLE DRUGS MARKET SIZE, BY HORMONAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 217. ITALY STERILE INJECTABLE DRUGS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 218. ITALY STERILE INJECTABLE DRUGS MARKET SIZE, BY METABOLIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 219. ITALY STERILE INJECTABLE DRUGS MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 220. ITALY STERILE INJECTABLE DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 221. ITALY STERILE INJECTABLE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 222. SPAIN STERILE INJECTABLE DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 223. SPAIN STERILE INJECTABLE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 224. SPAIN STERILE INJECTABLE DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 225. SPAIN STERILE INJECTABLE DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 226. SPAIN STERILE INJECTABLE DRUGS MARKET SIZE, BY SINGLE DOSE, 2018-2030 (USD MILLION)
TABLE 227. SPAIN STERILE INJECTABLE DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 228. SPAIN STERILE INJECTABLE DRUGS MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
TABLE 229. SPAIN STERILE INJECTABLE DRUGS MARKET SIZE, BY HORMONAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 230. SPAIN STERILE INJECTABLE DRUGS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 231. SPAIN STERILE INJECTABLE DRUGS MARKET SIZE, BY METABOLIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 232. SPAIN STERILE INJECTABLE DRUGS MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 233. SPAIN STERILE INJECTABLE DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 234. SPAIN STERILE INJECTABLE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 235. UNITED ARAB EMIRATES STERILE INJECTABLE DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 236. UNITED ARAB EMIRATES STERILE INJECTABLE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 237. UNITED ARAB EMIRATES STERILE INJECTABLE DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 238. UNITED ARAB EMIRATES STERILE INJECTABLE DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 239. UNITED ARAB EMIRATES STERILE INJECTABLE DRUGS MARKET SIZE, BY SINGLE DOSE, 2018-2030 (USD MILLION)
TABLE 240. UNITED ARAB EMIRATES STERILE INJECTABLE DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 241. UNITED ARAB EMIRATES STERILE INJECTABLE DRUGS MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
TABLE 242. UNITED ARAB EMIRATES STERILE INJECTABLE DRUGS MARKET SIZE, BY HORMONAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 243. UNITED ARAB EMIRATES STERILE INJECTABLE DRUGS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 244. UNITED ARAB EMIRATES STERILE INJECTABLE DRUGS MARKET SIZE, BY METABOLIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 245. UNITED ARAB EMIRATES STERILE INJECTABLE DRUGS MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 246. UNITED ARAB EMIRATES STERILE INJECTABLE DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 247. UNITED ARAB EMIRATES STERILE INJECTABLE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 248. SAUDI ARABIA STERILE INJECTABLE DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 249. SAUDI ARABIA STERILE INJECTABLE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 250. SAUDI ARABIA STERILE INJECTABLE DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 251. SAUDI ARABIA STERILE INJECTABLE DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 252. SAUDI ARABIA STERILE INJECTABLE DRUGS MARKET SIZE, BY SINGLE DOSE, 2018-2030 (USD MILLION)
TABLE 253. SAUDI ARABIA STERILE INJECTABLE DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 254. SAUDI ARABIA STERILE INJECTABLE DRUGS MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
TABLE 255. SAUDI ARABIA STERILE INJECTABLE DRUGS MARKET SIZE, BY HORMONAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 256. SAUDI ARABIA STERILE INJECTABLE DRUGS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 257. SAUDI ARABIA STERILE INJECTABLE DRUGS MARKET SIZE, BY METABOLIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 258. SAUDI ARABIA STERILE INJECTABLE DRUGS MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 259. SAUDI ARABIA STERILE INJECTABLE DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 260. SAUDI ARABIA STERILE INJECTABLE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 261. SOUTH AFRICA STERILE INJECTABLE DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 262. SOUTH AFRICA STERILE INJECTABLE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 263. SOUTH AFRICA STERILE INJECTABLE DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 264. SOUTH AFRICA STERILE INJECTABLE DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 265. SOUTH AFRICA STERILE INJECTABLE DRUGS MARKET SIZE, BY SINGLE DOSE, 2018-2030 (USD MILLION)
TABLE 266. SOUTH AFRICA STERILE INJECTABLE DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 267. SOUTH AFRICA STERILE INJECTABLE DRUGS MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
TABLE 268. SOUTH AFRICA STERILE INJECTABLE DRUGS MARKET SIZE, BY HORMONAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 269. SOUTH AFRICA STERILE INJECTABLE DRUGS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 270. SOUTH AFRICA STERILE INJECTABLE DRUGS MARKET SIZE, BY METABOLIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 271. SOUTH AFRICA STERILE INJECTABLE DRUGS MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 272. SOUTH AFRICA STERILE INJECTABLE DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 273. SOUTH AFRICA STERILE INJECTABLE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 274. DENMARK STERILE INJECTABLE DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 275. DENMARK STERILE INJECTABLE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 276. DENMARK STERILE INJECTABLE DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 277. DENMARK STERILE INJECTABLE DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 278. DENMARK STERILE INJECTABLE DRUGS MARKET SIZE, BY SINGLE DOSE, 2018-2030 (USD MILLION)
TABLE 279. DENMARK STERILE INJECTABLE DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 280. DENMARK STERILE INJECTABLE DRUGS MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
TABLE 281. DENMARK STERILE INJECTABLE DRUGS MARKET SIZE, BY HORMONAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 282. DENMARK STERILE INJECTABLE DRUGS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 283. DENMARK STERILE INJECTABLE DRUGS MARKET SIZE, BY METABOLIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 284. DENMARK STERILE INJECTABLE DRUGS MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 285. DENMARK STERILE INJECTABLE DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 286. DENMARK STERILE INJECTABLE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 287. NETHERLANDS STERILE INJECTABLE DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 288. NETHERLANDS STERILE INJECTABLE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 289. NETHERLANDS STERILE INJECTABLE DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 290. NETHERLANDS STERILE INJECTABLE DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 291. NETHERLANDS STERILE INJECTABLE DRUGS MARKET SIZE, BY SINGLE DOSE, 2018-2030 (USD MILLION)
TABLE 292. NETHERLANDS STERILE INJECTABLE DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 293. NETHERLANDS STERILE INJECTABLE DRUGS MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
TABLE 294. NETHERLANDS STERILE INJECTABLE DRUGS MARKET SIZE, BY HORMONAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 295. NETHERLANDS STERILE INJECTABLE DRUGS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 296. NETHERLANDS STERILE INJECTABLE DRUGS MARKET SIZE, BY METABOLIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 297. NETHERLANDS STERILE INJECTABLE DRUGS MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 298. NETHERLANDS STERILE INJECTABLE DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 299. NETHERLANDS STERILE INJECTABLE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 300. QATAR STERILE INJECTABLE DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 301. QATAR STERILE INJECTABLE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 302. QATAR STERILE INJECTABLE DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 303. QATAR STERILE INJECTABLE DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 304. QATAR STERILE INJECTABLE DRUGS MARKET SIZE, BY SINGLE DOSE, 2018-2030 (USD MILLION)
TABLE 305. QATAR STERILE INJECTABLE DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 306. QATAR STERILE INJECTABLE DRUGS MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
TABLE 307. QATAR STERILE INJECTABLE DRUGS MARKET SIZE, BY HORMONAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 308. QATAR STERILE INJECTABLE DRUGS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 309. QATAR STERILE INJECTABLE DRUGS MARKET SIZE, BY METABOLIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 310. QATAR STERILE INJECTABLE DRUGS MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 311. QATAR STERILE INJECTABLE DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 312. QATAR STERILE INJECTABLE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 313. FINLAND STERILE INJECTABLE DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 314. FINLAND STERILE INJECTABLE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 315. FINLAND STERILE INJECTABLE DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 316. FINLAND STERILE INJECTABLE DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-203

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Sterile Injectable Drugs market report include:
  • Adare Pharma Solutions
  • Aenova Group
  • Almac Group
  • Avara Pharmaceutical Services, Inc.
  • Baxter International Inc.
  • Boehringer Ingelheim International GmbH
  • Catalent, Inc.
  • CordenPharma
  • Eli Lilly and Company
  • Evonik Industries AG
  • F. Hoffmann-La Roche Ltd
  • Famar Group
  • Fresenius Kabi AG
  • Grifols S.A.
  • Hikma Pharmaceuticals PLC
  • Jubilant Pharmova Limited
  • Nexus Pharmaceuticals, Inc.
  • Patheon by hermo Fisher Scientific Inc.
  • Pfizer Inc.
  • Recipharm AB
  • Serum Institute of India Pvt. Ltd.
  • Siegfried Holding AG

Table Information

Report AttributeDetails
No. of Pages183
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 592.97 Billion
Forecasted Market Value ( USD ) by 2030 $ 856.5 Billion
Compound Annual Growth Rate7.6%
Regions CoveredGlobal
No. of Companies Mentioned23

Related Topics

Related Reports

Sterile Injectables CDMO Market Size, Share & Trends Analysis Report By Molecule Type (Small Molecule, Large Molecule), By Product, By Service, By Therapeutic Area, By Route Of Administration, By End-use, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Sterile Injectables CDMO Market Size, Share & Trends Analysis Report By Molecule Type (Small Molecule, Large Molecule), By Product, By Service, By Therapeutic Area, By Route Of Administration, By End-use, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 180 Pages
  • Global
From
Sterile Injectable Drugs - Global Strategic Business Report - Product Image

Sterile Injectable Drugs - Global Strategic Business Report

  • Report
  • 194 Pages
  • Global
From
Sterile Injectables CDMO - Global Strategic Business Report - Product Image

Sterile Injectables CDMO - Global Strategic Business Report

  • Report
  • 67 Pages
  • Global
From
Sterile Injectable Contract Manufacturing - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2024 - 2029) - Product Image

Sterile Injectable Contract Manufacturing - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2024 - 2029)

  • Report
  • 120 Pages
  • Global
From
Generic Oncology Sterile Injectable Market Report 2025 - Product Image

Generic Oncology Sterile Injectable Market Report 2025

  • Report
  • 200 Pages
  • Global
From

About the Sterile Injectable Drugs Market

The Sterile Injectable Drugs market is a segment of the Pharmaceuticals industry that focuses on the production and distribution of sterile injectable drugs. These drugs are typically administered intravenously, intramuscularly, or subcutaneously and are used to treat a variety of medical conditions. Sterile injectable drugs are highly regulated and must meet stringent safety and quality standards. The market is driven by the increasing prevalence of chronic diseases, such as cancer, diabetes, and cardiovascular diseases, as well as the growing demand for biologics and biosimilars. Additionally, the rising demand for self-administered injectable drugs, such as insulin, is expected to drive the market. Some of the major companies in the Sterile Injectable Drugs market include Pfizer, Merck, Novartis, Sanofi, and Johnson & Johnson. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.